Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Oct 23, 2009

NEW YORK (GenomeWeb News) - CombiMatrix has named Chris Emery and Lony Lim to serve as COO and VP of operations, respectively, of its CombiMatrix Molecular Diagnostic subsidiary.

Emery previously was a marketing manager with US Labs, a division of LabCorp, and he was VP of sales and marketing at Response Genetics. Lim was director of scientific affairs, flow cytometry, and anatomic pathology at US Labs and scientific director of the division of immunology at Ameripath Specialty Laboratories, and he helped pioneer Luminex's xMAP technology, said CombiMatrix.


Pacific Biosciences has appointed Evan Eichler, a professor of genome sciences at the University of Washington School of Medicine, to its scientific advisory board. Eichler's research focuses on evolution, pathology, and gene duplication and DNA transposition in the human genome.


Paul Laikind will join the Burnham Institute for Medical Research as senior VP of business development and chief business officer. Laikind is co-founder of Gensia Pharmaceuticals, Viagene, and Metabasis Therapeutics, where he recently was president and CEO and remains on the board of directors. Life Technologies CEO and Burnham's Chairman of the Board of Trustees, Gregory Lucier, in a statement said that the institute is "bringing in the talent we need to strategically evaluate our research assets and position them, through licenses, collaborations or spin-outs, for commercialization."


Kenneth Berns, director of the University of Florida Genetics Institute, has been invited to serve on the board of the National Science Advisory Board for Biosecurity, a panel that advises the Department of Health and Human Services and the National Institutes of Health.


Robert Desnick has been appointed Dean for Genetics and Genomics for the Mount Sinai School of Medicine. Desnick currently is a professor and chair of the Department of Genetics and Genomics at Mount Sinai. He formerly was chair of the Association of American Medical Colleges and he currently serves on its board of directors. He has been on Mount Sinai's faculty since 1977, and he has served as director of the American Board of Medical Genetics.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.